title: [Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate].
authors.affiliation: Dept. of Internal Medicine, Gihoku General Hospital.
authors.forename: T
authors.initials: T
authors.lastname: Arai
authors.forename: S
authors.initials: S
authors.lastname: Narimiya
authors.forename: K
authors.initials: K
authors.lastname: Hayakawa
authors.forename: T
authors.initials: T
authors.lastname: Takaya
authors.forename: S
authors.initials: S
authors.lastname: Toshima
authors.forename: M
authors.initials: M
authors.lastname: Araki
authors.forename: A
authors.initials: A
authors.lastname: Uchida
authors.forename: N
authors.initials: N
authors.lastname: Yoshimi
authors.forename: C
authors.initials: C
authors.lastname: Shibuya
authors.forename: Y
authors.initials: Y
authors.lastname: Yasuda
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001088:Arabinonucleotides / Q000627:therapeutic use*; D003568:Cytidine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001088:Arabinonucleotides; C061162:1-arabinofuranosylcytosine-5'-stearylphosphate; D003568:Cytidine Monophosphate